de Yébenes Virginia G, Belver Laura, Pisano David G, González Susana, Villasante Aranzazu, Croce Carlo, He Lin, Ramiro Almudena R
DNA Hypermutation and Cancer Group, Spanish National Cancer Research Center, Madrid 28029, Spain.
J Exp Med. 2008 Sep 29;205(10):2199-206. doi: 10.1084/jem.20080579. Epub 2008 Sep 1.
Activated B cells reshape their primary antibody repertoire after antigen encounter by two molecular mechanisms: somatic hypermutation (SHM) and class switch recombination (CSR). SHM and CSR are initiated by activation-induced cytidine deaminase (AID) through the deamination of cytosine residues on the immunoglobulin loci, which leads to the generation of DNA mutations or double-strand break intermediates. As a bystander effect, endogenous AID levels can also promote the generation of chromosome translocations, suggesting that the fine tuning of AID expression may be critical to restrict B cell lymphomagenesis. To determine whether microRNAs (miRNAs) play a role in the regulation of AID expression, we performed a functional screening of an miRNA library and identified miRNAs that regulate CSR. One such miRNA, miR-181b, impairs CSR when expressed in activated B cells, and results in the down-regulation of AID mRNA and protein levels. We found that the AID 3' untranslated region contains multiple putative binding sequences for miR-181b and that these sequences can be directly targeted by miR-181b. Overall, our results provide evidence for a new regulatory mechanism that restricts AID activity and can therefore be relevant to prevent B cell malignant transformation.
活化的B细胞在遇到抗原后通过两种分子机制重塑其主要抗体库:体细胞高频突变(SHM)和类别转换重组(CSR)。SHM和CSR由活化诱导的胞苷脱氨酶(AID)启动,通过对免疫球蛋白基因座上的胞嘧啶残基进行脱氨作用,从而导致DNA突变或双链断裂中间体的产生。作为一种旁观者效应,内源性AID水平也可促进染色体易位的产生,这表明对AID表达的精细调节可能对限制B细胞淋巴瘤的发生至关重要。为了确定微小RNA(miRNA)是否在AID表达的调节中发挥作用,我们对一个miRNA文库进行了功能筛选,并鉴定出了调节CSR的miRNA。其中一种miRNA,即miR-181b,在活化的B细胞中表达时会损害CSR,并导致AID mRNA和蛋白水平的下调。我们发现AID的3'非翻译区包含多个miR-181b的假定结合序列,并且这些序列可被miR-181b直接靶向。总体而言,我们的结果为一种限制AID活性的新调节机制提供了证据,因此可能与预防B细胞恶性转化相关。